Bala NS, Stanek JR, Vesely SK, et al. Comparison of thromboembolism outcomes in patients with sickle cell disease prescribed hormonal contraception. Blood Adv. 2023;7(20):6140-6150.

In the online version of this article, the visual abstract contained transposed percentages for patients who received prescriptions for combined hormonal contraception (CHC) and progestin-only contraception (POC). The percentage of patients who received a prescription for CHC should be 44.6% and the percentage of patients who received a prescription for POC should be 55.4%. The corrected visual abstract is below: